** Shares of Ansell rise as much as 4.7% to A$32.900, hitting their highest level since Jan 25, 2022
** Stock set for strongest trading session since late August
** Medical equipments supplier revises FY25 adj EPS outlook range to 110-127 US cents from 107-127 US cents
** However, co says higher inflation costs of key raw materials and higher freight costs to have greater impact in H2 FY25
** Stock up 24.8% YTD, as of last close
(Reporting by Shivangi Lahiri in Bengaluru)
((shivangi.lahiri@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。